Cargando…

Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments

PURPOSE: To determine the effect of revascularisation for peripheral arterial disease (PAD) on QoL in the first and second year following diagnosis, to compare the effect depicted by Short Form Six Dimensions (SF-6D) and EuroQoL five Dimensions (EQ-5D) utilities, and Visual Analogue Scale (VAS) scor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petersohn, Svenja, Ramaekers, Bram L. T., Olie, Renske H., ten Cate-Hoek, Arina J., Daemen, Jan-Willem H. C., ten Cate, Hugo, Joore, Manuela A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620242/ https://www.ncbi.nlm.nih.gov/pubmed/30929124 http://dx.doi.org/10.1007/s11136-019-02166-0

Ejemplares similares

Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study
por: Petersohn, Svenja, et al.
Publicado: (2020)

Screen or not to screen for peripheral arterial disease: guidance from a decision model
por: Vaidya, Anil, et al.
Publicado: (2014)

Development of a Consensus-Based Cross-Domain Protocol for the Management of Elastic Compression Stocking Therapy in Patients With Deep Venous Thrombosis and Chronic Venous Disease: A Modified Delphi Study
por: Schreurs, Rachel H. P., et al.
Publicado: (2022)

Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands
por: Schreurs, Rachel H. P., et al.
Publicado: (2023)

Using the Functional Resonance Analysis Method to explore how elastic compression therapy is organised and could be improved from a multistakeholder perspective
por: Schreurs, Rachel Hellen Petra, et al.
Publicado: (2021)

The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2014)

A realist evaluation to identify targets to improve the organization of compression therapy for deep venous thrombosis- and chronic venous disease patients
por: Schreurs, Rachel H. P., et al.
Publicado: (2022)

Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis
por: Kremers, Bram, et al.
Publicado: (2020)

Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review
por: Notten, Pascale, et al.
Publicado: (2021)

Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction
por: Nagler, Michael, et al.
Publicado: (2018)

Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
por: Kleinegris, Marie-Claire F., et al.
Publicado: (2017)

Residual Venous Obstruction as an Indicator of Clinical Outcomes following Deep Vein Thrombosis: A Management Study
por: Iding, Aaron F. J., et al.
Publicado: (2023)

Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach
por: Bouman, A. C., et al.
Publicado: (2015)

Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review
por: Zwaveling, Suzanne, et al.
Publicado: (2018)

Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing
por: Bloemen, Saartje, et al.
Publicado: (2017)

P1647: CHRONIC INFLAMMATORY DISEASES INCREASE THE RISK OF POST-THROMBOTIC SYNDROME: A PROSPECTIVE COHORT STUDY
por: Iding, Aaron F.J., et al.
Publicado: (2023)

Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study
por: Notten, Pascale, et al.
Publicado: (2020)

Prevention and treatment of the post‐thrombotic syndrome
por: ten Cate‐Hoek, Arina J.
Publicado: (2018)

The coagulation system in atherothrombosis: Implications for new therapeutic strategies
por: Olie, Renske H., et al.
Publicado: (2018)

Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
por: Nagler, Michael, et al.
Publicado: (2021)

P1643: FIBRIN CLOT PROPERTIES IDENTIFY PATIENTS THAT BENEFIT FROM CATHETER-DIRECTED THROMBOLYSIS: A POST HOC ANALYSIS OF THE CAVA TRIAL
por: Iding, Aaron F.J., et al.
Publicado: (2023)

Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease
por: Kremers, Bram M. M., et al.
Publicado: (2019)

Postoperative thromboembolic prophylaxis in joint replacement surgery: Guidelines and daily practice
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2012)

Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study
por: Kremers, B. M. M., et al.
Publicado: (2023)

Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting
por: Notten, Pascale, et al.
Publicado: (2020)

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Grimm, Sabine E., et al.
Publicado: (2019)

Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease
por: Kremers, B. M. M., et al.
Publicado: (2022)

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study
por: Gulpen, Anouk J. W., et al.
Publicado: (2019)

A known unknown? Pharmacological prevention of venous thromboembolism in nursing home residents
por: Brüggemann, Renée A. G., et al.
Publicado: (2021)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Mortality and the Use of Antithrombotic Therapies Among Nursing Home Residents with COVID‐19
por: Brouns, Steffie H., et al.
Publicado: (2020)

New oral anticoagulants: discussion on monitoring and adherence should start now!
por: ten Cate, Hugo
Publicado: (2013)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

Thrombosis management in times of COVID-19 epidemy; a Dutch perspective
por: ten Cate, Hugo
Publicado: (2020)

Colorectal cancer and cardiovascular disease: A thrombo-inflammatory link?
por: ten Cate, Hugo
Publicado: (2021)

Surviving Covid-19 with Heparin?
por: ten Cate, Hugo
Publicado: (2021)

Thrombosis: Grand Challenges Ahead!
por: ten Cate, Hugo
Publicado: (2021)

Editorial: Insights in thrombosis: 2021
por: ten Cate, Hugo
Publicado: (2022)

Platelet Dysfunction in Thrombosis Patients Treated with Vitamin K Antagonists and Recurrent Bleeding
por: van der Meijden, Paola E. J., et al.
Publicado: (2013)

Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate?
por: ten Cate, Hugo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cuv86qlm0s73663da904nvaqmc